Sponsor or institution
Clinical trials and research at Ensem Therapeutics
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Ensem Therapeutics that are recruiting, at sites in 2 countries (most in United States (2), China (1)). 1 was first registered in the last 30 days. By phase: Phase 1/2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1New in 30 days
- 2Countries
All recruiting trials (2)
-
KRAS Inhibitor ETX-929 in advanced solid tumors
This trial tests ETX-929, alone or with cetuximab, in people whose cancers have KRAS mutations and have progressed after prior therapy.
-
ETX-636 treatment for advanced PIK3CA-mutant solid tumors and HR+ HER2- breast cancer
This will test ETX-636 alone and together with fulvestrant in people with advanced solid tumors that have a PIK3CA mutation, including HR+, HER2- breast cancer.
Quick answers
How many clinical trials run by Ensem Therapeutics are recruiting right now?
2, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (2 trials), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.